Price
Financials
Standalone, Rs crore| Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | |
|---|---|---|---|---|---|---|---|
| Sales | 0.44 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 2.66 |
| Expenses | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.01 |
| Operating Profit | 0.41 | -0.01 | -0.01 | -0.01 | 0.03 | 0.02 | 2.65 |
| OPM % | 93.18% | 60.00% | 40.00% | 99.62% | |||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Profit before tax | 0.35 | -0.07 | -0.07 | -0.07 | -0.03 | -0.04 | 2.59 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.16% |
| Net Profit | 0.35 | -0.07 | -0.07 | -0.07 | -0.03 | -0.04 | 2.62 |
| EPS in Rs |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.76 |
| Expenses | 0.06 | 0.08 | 0.03 | 0.02 | 0.03 | 0.06 | 0.07 |
| Operating Profit | 0.13 | -0.08 | -0.03 | -0.02 | -0.03 | -0.06 | 2.69 |
| OPM % | 68.42% | 97.46% | |||||
| Other Income | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.25 | 0.25 | 0.24 | 0.25 | 0.25 | 0.24 | 0.24 |
| Profit before tax | -0.11 | -0.33 | -0.27 | -0.27 | -0.28 | -0.26 | 2.45 |
| Tax % | -18.18% | -9.09% | -11.11% | -14.81% | -14.29% | -15.38% | |
| Net Profit | -0.09 | -0.30 | -0.24 | -0.23 | -0.24 | -0.22 | 2.48 |
| EPS in Rs | |||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | % | ||
| Compounded Profit Growth | % | % | 3% | 8% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | -8% | -8% | -9% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Equity Capital | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
| Reserves | -4.92 | -5.22 | -5.47 | -5.70 | -5.93 | -6.15 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.29 | 1.44 | 1.40 | 1.34 | 1.30 | 1.24 |
| Total Liabilities | 4.90 | 4.75 | 4.46 | 4.17 | 3.90 | 3.62 |
| Fixed Assets | 4.50 | 4.25 | 4.00 | 3.76 | 3.51 | 3.27 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.40 | 0.50 | 0.46 | 0.41 | 0.39 | 0.35 |
| Total Assets | 4.90 | 4.75 | 4.46 | 4.17 | 3.90 | 3.62 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.23 | 0.00 | -0.02 | 0.01 | -0.01 | 0.01 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activity | -0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | -0.01 | 0.00 | -0.02 | 0.01 | -0.01 | 0.01 |
| Free Cash Flow | 0.23 | 0.00 | -0.02 | 0.01 | -0.01 | 0.01 |
| CFO/OP | 177% | 0% | 67% | -50% | 33% | -17% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | |||||
| Inventory Days | ||||||
| Days Payable | ||||||
| Cash Conversion Cycle | 0.00 | |||||
| Working Capital Days | -268.95 | |||||
| ROCE % | -9.54% | -8.48% | -9.17% | -10.31% | -10.44% |
Fundamentals
Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE-10.4 %
ROE-8.84 %
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)8%
Standalone figures.
Profitability
ROE-8.67%
ROCE-9.54%
ROA-6.22%
ROIC (approx.)3.89%
Tax rate9.09%
Per share
EPS (TTM)Rs 0.16
EPS (latest year)Rs -0.35
EPS (latest quarter)Rs -0.08
Book value per shareRs 3.86
Free cash flow per shareRs 0.01
Efficiency
Cash conversion cycle0 days
Working capital days-269 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-0.11x
Owners' fund to total sources69.68%
Cash flow
Free cash flow (latest year)Rs 0 Cr
Statement figures
Operating profit (latest quarter)Rs -0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs -0 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 9 Cr
ReservesRs -5 Cr
Shareholders' fundsRs 3 Cr
Total assetsRs 5 Cr
Net blockRs 4 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)0.86
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Sep 2014Sales ₹3 Cr.
Net profit ₹3 Cr +3842.9%.
Activity
CompareNo listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Coromandal Biotech Industries (India) Ltd?
Coromandal Biotech Industries (India) Ltd (519293) has a market capitalisation of Rs Cr. at the close.
What were Coromandal Biotech Industries (India) Ltd's latest quarterly results?
In the Sep 2014 quarter, Coromandal Biotech Industries (India) Ltd sales was Rs 3 Cr and net profit was Rs 3 Cr.